- Home
- WLGS vs BGLC Comparison
WLGS vs BGLC Comparison
Compare WLGS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- BGLC
- Stock Information
- Founded
- WLGS 1981
- BGLC 2017
- Country
- WLGS Hong Kong
- BGLC Malaysia
- Employees
- WLGS N/A
- BGLC N/A
- Industry
- WLGS Engineering & Construction
- BGLC Medical Specialities
- Sector
- WLGS Consumer Discretionary
- BGLC Health Care
- Exchange
- WLGS Nasdaq
- BGLC Nasdaq
- Market Cap
- WLGS 4.4M
- BGLC 5.0M
- IPO Year
- WLGS 2023
- BGLC N/A
- Fundamental
- Price
- WLGS $0.05
- BGLC $2.71
- Analyst Decision
- WLGS
- BGLC
- Analyst Count
- WLGS 0
- BGLC 0
- Target Price
- WLGS N/A
- BGLC N/A
- AVG Volume (30 Days)
- WLGS 37.9M
- BGLC 69.9K
- Earning Date
- WLGS 08-14-2025
- BGLC 08-13-2025
- Dividend Yield
- WLGS N/A
- BGLC N/A
- EPS Growth
- WLGS N/A
- BGLC N/A
- EPS
- WLGS N/A
- BGLC N/A
- Revenue
- WLGS $3,951,649.00
- BGLC $9,265,870.00
- Revenue This Year
- WLGS N/A
- BGLC N/A
- Revenue Next Year
- WLGS N/A
- BGLC N/A
- P/E Ratio
- WLGS N/A
- BGLC N/A
- Revenue Growth
- WLGS N/A
- BGLC N/A
- 52 Week Low
- WLGS $0.04
- BGLC $2.01
- 52 Week High
- WLGS $9.66
- BGLC $8.40
- Technical
- Relative Strength Index (RSI)
- WLGS 25.41
- BGLC 43.64
- Support Level
- WLGS $0.05
- BGLC $2.60
- Resistance Level
- WLGS $0.05
- BGLC $3.06
- Average True Range (ATR)
- WLGS 0.02
- BGLC 0.21
- MACD
- WLGS 0.01
- BGLC -0.06
- Stochastic Oscillator
- WLGS 3.27
- BGLC 16.27
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.